Literature DB >> 11976867

Imaging of chronic posttraumatic osteomyelitis.

Achim H Kaim1, Thomas Gross, Gustav K von Schulthess.   

Abstract

Posttraumatic osteomyelitis is frequently characterized by chronicity and recurrent activation of infection. The diagnosis is usually made on the basis of clinical, laboratory, and imaging examinations. The conventional radiograph is the basic imaging study that provides important information about skeletal deformity, bone quality, identification of metallic implants, and consolidation of the former fracture site. Other imaging techniques are required to determine the grade of activity, to define the extent of infection and to delineate small sequestra, intraosseus fistula and abscesses. A variety of more sophisticated modalities, such as modern cross-sectional imaging and radionuclide studies, are available, and the decision to choose the most suitable method can be very difficult. This review gives an overview of definition, epidemiology, and pathophysiology of chronic posttraumatic osteomyelitis and discusses the value of currently used imaging modalities.

Entities:  

Mesh:

Year:  2001        PMID: 11976867     DOI: 10.1007/s00330-001-1141-0

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  13 in total

1.  Brodie abscess: another type of chronic posttraumatic osteomyelitis.

Authors:  Ali Guermazi; Andreas Mohr; Harry K Genant
Journal:  Eur Radiol       Date:  2003-02-07       Impact factor: 5.315

2.  The value of FDG-PET in patients with painful total knee arthroplasty.

Authors:  Katrin D M Stumpe; Jose Romero; Oliver Ziegler; Ehab M Kamel; Gustav K von Schulthess; Klaus Strobel; Juerg Hodler
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-05-24       Impact factor: 9.236

3.  Gray-scale and color Doppler ultrasonographic evaluation of reactivated post-traumatic/postoperative chronic osteomyelitis.

Authors:  A P Balanika; O Papakonstantinou; C J Kontopoulou; C S Baltas; S Athanassia; K Kanelakopoulou; E Brountzos; A Gouliamos; N L Kelekis
Journal:  Skeletal Radiol       Date:  2008-12-10       Impact factor: 2.199

Review 4.  Radionuclide imaging of spinal infections.

Authors:  Filip Gemmel; Nicolas Dumarey; Christopher J Palestro
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-10       Impact factor: 9.236

5.  Reconstruction of osteomyelitis defects.

Authors:  Paul Dinh; Brian K Hutchinson; Charalampos Zalavras; Milan V Stevanovic
Journal:  Semin Plast Surg       Date:  2009-05       Impact factor: 2.314

6.  Comparative Analysis of 99mTc-MDP Three-Phase Bone Scan with SPECT/CT and 99mTc-HMPAO-Labeled WBC SPECT/CT in the Differential Diagnosis of Clinically Suspicious Post-traumatic Osteomyelitis.

Authors:  Chanwoo Kim; Soo Jin Lee; Ji Young Kim; Kyu Tae Hwang; Yun Young Choi
Journal:  Nucl Med Mol Imaging       Date:  2016-08-04

7.  Diagnostic value of 18F-FDG PET/CT in trauma patients with suspected chronic osteomyelitis.

Authors:  Anna Hartmann; Karim Eid; Claudio Dora; Otmar Trentz; Gustav K von Schulthess; Katrin D M Stumpe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-11-29       Impact factor: 9.236

Review 8.  Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation.

Authors:  Alexander Neuwelt; Navneet Sidhu; Chien-An A Hu; Gary Mlady; Steven C Eberhardt; Laurel O Sillerud
Journal:  AJR Am J Roentgenol       Date:  2015-03       Impact factor: 3.959

Review 9.  Expanding role of 18F-fluoro-D-deoxyglucose PET and PET/CT in spinal infections.

Authors:  Filip Gemmel; Paul C Rijk; James M P Collins; Thierry Parlevliet; Katrin D Stumpe; Christopher J Palestro
Journal:  Eur Spine J       Date:  2010-01-06       Impact factor: 3.134

10.  99mTc-ciprofloxacin planar and tomographic imaging for the diagnosis of infection in the postoperative spine: experience in 48 patients.

Authors:  Frederic De Winter; Filip Gemmel; Koen Van Laere; Olivier De Winter; Bart Poffijn; Rudi A Dierckx; Christophe Van de Wiele
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.